Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Changes to coverage policies for ventricular assist devices will impact heart failure device market, says GlobalData

The Centers for Medicare & Medicaid Services (CMS) in the US has issued a statement indicating their proposal to increase access to ventricular access devices (VADs) for patients living with severe heart conditions, including a specific update to the criteria for treatment with a Total Artificial Heart (TAH). Leading data and analystics company GlobalData expects […]
Read more

Thermo Fisher’s failed Qiagen acquisition will not significantly affect its future growth

Following the collapse of Thermo Fisher Scientific’s $11.5bn takeover of Qiagen; Brian Hicks, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view: “As one of the largest acquisitions in the MedTech industry to have potentially occurred in 2020, a successful deal would have propelled Thermo Fisher’s market capitalization by nearly 7%, […]
Read more

Guardant Health expected to see continued revenue as EGFR test a much-needed boon for NSCLC space, says GlobalData

Following the FDA’s approval of Guardant Health’s liquid biopsy comprehensive tumor mutation profiling across all solid cancers; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “This is a landmark approval for cancer testing as Guardant Health’s liquid biopsy is the first of its kind to genetically profile […]
Read more

Wearable tech market set to grow 137% by 2024 but smartwatches to see a 10% decline in revenue this year due to shipment delays and tighter consumer wallets, says GlobalData

Wearables have seen significant growth in the medical market over the past several years due to their potential to address spiraling healthcare costs, aging populations, and the burden of chronic disease. According to GlobalData, the wearable tech market was worth nearly $27bn in 2019 and is likely to grow to $64bn by 2024 due to […]
Read more

ResMed benefits from rising ventilator market, which sees forecast upwards adjustment of $3.8bn, says GlobalData

Following ResMed’s fiscal fourth quarter revenue report: Kamilla Kan, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view on the recent news: “ResMed’s year-over-year increase of 9% in revenue is largely due to the increase in sales and production of ventilators due to COVID-19. COVID-19 has had a profound effect […]
Read more

COVID-19 pandemic severely impacting US reversible contraceptive devices market with 28.9% lost revenue expected in 2020, says GlobalData

Nearly 30% of revenue from reversible contraceptive devices in the US will be lost in 2020 due to COVID-19, as many procedures have been postponed and clinics have been closed. In comparison, developing countries are expected to experience a less severe decline, as governments have previously dealt with providing reproductive health during pandemics such as […]
Read more

FDA multiple-function device products update particularly affects telehealth, says GlobalData

Following Food and Drug Administration (FDA) announcement that guidelines on multiple-function devices were finalized; Kamilla Kan, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view on the recent news: “In its latest guidance update, the FDA’s advise that manufacturers should review whether the other functions of a medical device impact […]
Read more

China’s ventilators market to grow at CAGR of 7.1% between 2019 and 2030, forecasts GlobalData

The ventilators market in China is expected to grow at a compound annual growth rate (CAGR) of 7.1% between 2019 and 2030, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Ventilators (Anesthesia and Respiratory Devices) – Global Market Analysis and Forecast Model (COVID-19 market impact)’, reveals that in 2019 China holds […]
Read more

Expanding allowed procedures for ASCs will lead to strongly performing healthcare environment in pandemic-stricken world, says GlobalData

Following several proposed changes to the CMS’ reimbursement schemes, healthcare in America may be becoming more decentralized in the future. James Spencer, Data Scientist at GlobalData, a leading data and analytics company, offers his view on the current approach to reopening the US economy: “Slow consolidation of the US healthcare infrastructure has resulted in the […]
Read more
,

Siemens Healthineers-Varian deal will create a world leader in oncology solutions, says GlobalData

Following the recent announcement that Siemens Healthineers will acquire Varian Medical Systems; Aurojyoti Bose, Lead Analyst at GlobalData, a leading data and analytics company, offers his view on the deal: “This US$16.4bn deal is the largest transaction by Siemens Healthineers since it was spun-off and formed as a separate business entity by Siemens in 2018. […]
Read more

Quidel’s revenues will continue to climb in 2020

Following the release of Quidel’s Q2 2020 results; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “Quidel has risen dramatically this year due to its flexible, diverse and speedy COVID-19 offerings. With the pandemic still present, especially in the US and South America, and the threat of […]
Read more

Spinal fusion market gradually recovers from COVID-19 pandemic

The spinal fusion market has been severely affected by the COVID-19 pandemic. Leading data and analytics company GlobalData forecast the spinal fusion market will decline from $7bn to $5.9bn, with a decrease of 16.2% in 2020. However, the market is starting to recover as elective surgeries gradually resume globally. Tina Deng, MSc, Senior Medical Devices […]
Read more

Transcatheter heart valve replacement market expected to execute a miraculous recovery, says GlobalData

Following Edwards Lifesciences’ announcement of an expected 5% growth for its transcatheter aortic valve replacement (TAVR) business, GlobalData observes hopeful signs of resiliency in the TAVR market. James Spencer, Data Scientist at GlobalData, a leading data and analytics company, offers his view on the current approach to reopening America’s economy: “COVID has tanked the global […]
Read more

Asymptomatic testing will be key in next phase of pandemic

Following the news LabCorp’s COVID-19 test received the first food and drug administration (FDA) emergency use authorization (EUA) for use in screening asymptomatic subjects; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “Asymptomatic testing will be key in the next phase of the pandemic as concerns about […]
Read more
1 … 40 41 42 43 44 … 51